New hope for newborn seizures: levetiracetam shows promise in early trial
NCT ID NCT02229123
First seen Jan 08, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tested the medicine levetiracetam as a first treatment for seizures in full-term newborns who had brain injury from lack of oxygen at birth. Researchers wanted to find the right dose and check if it was safe. The trial included 18 babies and monitored their brain activity and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEIZURES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Néonatologie
Rennes, 35000, France
-
Service de Néonatologie
Tours, 37 000, France
-
Service de Pédiatrie néonatale et réanimation
Rouen, 76031, France
-
Service de réanimation et service néonatale
Orléans, 45100, France
-
Service de réanimation néonatale
Angers, 49000, France
-
Service de réanimation néonatale
Lille, 59037, France
-
Service de réanimation néonatale
Reims, 51092, France
-
Service de réanimation néonatale et pédiatrique
Paris, 75012, France
Conditions
Explore the condition pages connected to this study.